AN

ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

Designs, develops, and manufactures molecular diagnostic solutions and instruments.

ANGEN | IS

Overview

Corporate Details

ISIN(s):
TREANGN00010 (+1 more)
LEI:
789000SFK2PSN72IVM96
Country:
Türkiye
Address:
İSTANBUL PLAZA KASAP İSMAİL SOK.NO.10/22-23, 34722 ISTANBUL

Description

Anatolia Geneworks is a biotechnology company that designs, develops, and manufactures molecular diagnostic solutions. The company's main expertise lies in producing Real-Time Polymerase Chain Reaction (Real-Time PCR) kits, nucleic acid extraction kits, and automated instruments. Its product portfolio includes the Bosphore line of Real-Time PCR kits for detecting pathogens related to conditions like sepsis, gastroenteritis, and hepatitis. It also offers the UNIO family of automated systems for nucleic acid isolation and PCR setup, providing integrated workflow solutions for laboratories in healthcare and genetic testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 07:53
Yeni Yatırım Teşvik Belgesi Hk.
Turkish 17.2 KB
2025-10-31 16:10
Sorumluluk Beyanı
Turkish 22.1 KB
2025-10-31 16:10
Faaliyet Raporu
Turkish 813.2 KB
2025-10-31 16:10
Faaliyet Raporu
English 11.1 KB
2025-10-31 16:10
Financial Report
English 1.4 MB
2025-10-31 16:10
Financial Report
Turkish 1.1 MB
2025-10-31 16:10
Financial Report
English 2.5 MB
2025-09-30 17:14
Company General Info Form
English 7.3 KB
2025-09-30 17:13
Mali İşler Direktörünün Görevinden Ayrılması Hk.
English 17.0 KB
2025-09-09 17:10
Participation Finance Principles Information Form
English 53.1 KB
2025-09-08 17:10
Participation Finance Principles Information Form
English 53.1 KB
2025-08-19 12:04
Esas Sözleşme Hk.
Turkish 205.2 KB
2025-08-19 12:04
Esas Sözleşme Hk.
English 22.2 KB
2025-08-19 12:04
Kayıtlı Sermaye Tavanına İlişkin Esas Sözleşme Maddesi Tadilinin Tescili Hk.
Turkish 1.2 MB
2025-08-19 12:04
Kayıtlı Sermaye Tavanına İlişkin Esas Sözleşme Maddesi Tadilinin Tescili Hk.
English 6.6 KB

Automate Your Workflow. Get a real-time feed of all ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060
Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.